JP Morgan Maintains Overweight on Qiagen, Raises Price Target to $60
Benzinga Newsdesk 9 months ago
NewsPrice TargetAnalyst Ratings
JP Morgan analyst Casey Woodring maintains Qiagen (NYSE:QGEN) with a Overweight and raises the price target from $55 to $60.
JP Morgan analyst Casey Woodring maintains Qiagen (NYSE:QGEN) with a Overweight and raises the price target from $55 to $60.